StockWatch
·
Biotechnology: Pharmaceutical Preparations
AGM/EGMNov 17, 2026, 04:46 PM

Enlivex Ltd. Calls EGM to Increase Authorized Share Capital

AI Summary

Enlivex Ltd. has announced an Extraordinary General Meeting (EGM) of shareholders to be held on December 4, 2026. The primary purpose of the EGM is to vote on a proposal to increase the company's authorized share capital from NIS 950,000,000 to NIS 9,120,000,000 and to amend the Articles of Association accordingly. The Board of Directors unanimously recommends a vote in favor of this proposal. The meeting will also cover quorum requirements and voting procedures. Information regarding share ownership by major shareholders and management is also provided.

Key Highlights

  • Enlivex Ltd. will hold an Extraordinary General Meeting on December 4, 2026.
  • Shareholders will vote on increasing authorized share capital from NIS 950M to NIS 9,120M.
  • The proposal includes amending the Company's Articles of Association.
  • The Board of Directors unanimously recommends voting 'FOR' the proposal.
  • Record date for voting eligibility is November 20, 2026.
  • A quorum requires at least two shareholders holding 25% of voting rights.